drug
as of 2026-07-01amantadine
Amantadine
MeSH D000547
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Eli Lilly and Company
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
NCT00999505Phase 3Unknown
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
NCT00401973Phase 3Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL